quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:35:00·81d
PRRelease
Perspective Therapeutics Inc. logo

Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

CATX· Perspective Therapeutics Inc.
Health Care
Original source

Companies

  • CATX
    Perspective Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Feb 19UpdatePiper Sandler$16.00
  • Nov 24UpdateTruist$12.00
  • Oct 10UpdateBTIG Research$14.00
  • Mar 13UpdateH.C. Wainwright$10.00
  • Mar 7UpdateScotiabank$15.00
  • Nov 25UpdateBofA Securities$5.00

Related

  • PR4h
    Perspective Therapeutics to Provide Several Upcoming Corporate Updates
  • SEC4d
    Perspective Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR4d
    Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting
  • SEC7d
    SEC Form DEFA14A filed by Perspective Therapeutics Inc.
  • SEC7d
    SEC Form DEF 14A filed by Perspective Therapeutics Inc.
  • PR22d
    Perspective Therapeutics to Participate in Upcoming Investor Conferences
  • SEC22d
    Perspective Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR37d
    Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022